Prime Minister Anthony Albanese leaves for China on Saturday, confident most Australians back the government’s handling of relations with our most important economic partner and the leading strategic power in Asia.

US President Donald Trump’s proposed tariffs on Australia’s pharmaceutical exports to the United States has raised alarm among industry and government leaders.

Peter Switzer and Paul Rickard weigh in on big opportunities—and big risks—across some of the ASX’s most-watched names. From gold stocks like Northern Star and Evolution, to high-growth tech players like Xero and Megaport, and takeover speculation around Santos, they break down what’s moving and what might surprise.

We now know a little more on what was taken in the Qantas hack, as the airline confirms that 5.7 million unique customers were compromised.

Australia’s key regulator of health professionals says it's clamping down on unsafe prescribing of medicinal cannabis.

Red Bull Racing, once the undisputed lords of F1, has just fired its team boss after two decades. Here's why it's seismic.

We wake this morning to a sea of green from US indexes overnight after what could be described as good news on tariffs. 

Cancer typically affects mostly older people. But some worrying trends show cancer rates in younger people aged under 50 are on the rise.

As times change, things stay the same at the Wimbledon championships, where “almost entirely white” kit is still a requirement. But why?

When buying a Tesla or other EV, there’s one big question that comes up: how long will the battery last before it starts to degrade?

The new financial year means the public will get to see previously unreleased tax reports produced by multinational taxpayers.

Australia’s superannuation regulator is concerned that superannuation funds might be spending in a way that's not benefiting members.